tp-0903
Showing 1 - 2 of 2
Chronic Lymphocytic Leukemia, CLL, SLL Trial in United States (TP-0903, TP-0903 and ibrutinib combination therapy)
Terminated
- Chronic Lymphocytic Leukemia
- +3 more
- TP-0903
- TP-0903 and ibrutinib combination therapy
-
Phoenix, Arizona
- +5 more
Apr 4, 2022
Advanced Solid Tumors, EGFR Positive NSCLC, Colorectal Carcinoma Trial in United States (TP-0903)
Active, not recruiting
- Advanced Solid Tumors
- +4 more
- TP-0903
-
Phoenix, Arizona
- +15 more
Apr 4, 2022